Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · U.S. Physical Therapy (USPH)

U.S. Physical Therapy shareholders elect eight directors, approve pay at May 20 meeting

Neutral Impact 2 of 5 shareholder Written later

At its annual meeting on May 20, 2025, U.S. Physical Therapy shareholders elected all eight director nominees and approved the advisory vote on named executive officer compensation. They also ratified Grant Thornton LLP as the independent registered public accounting firm for 2024. The filing reports routine shareholder votes, with no change in results or financial measures.

Key points

  • Eight directors elected, including Dr. Bernard A. Harris, Jr. (12,422,647 for; 1,175,315 withheld) and Nancy J. Ham (13,500,869 for; 97,093 withheld)
  • Advisory say-on-pay proposal approved: 12,429,355 for, 1,166,532 against, 2,075 abstaining, 565,839 broker non-votes
  • Grant Thornton LLP ratified as auditor for 2024: 14,019,968 for, 141,515 against, 2,318 abstaining

The filing

CompanyU.S. Physical Therapy (USPH)
Form8-K, current report
Filed with the SECMay 20, 2025, 4:43 PM ET
Accession number0000885978-25-000017

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 20, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.